MODERN CHI MED obtains Stock Exchange waiver, extends major-transaction circular deadline to 30 June 2026

Bulletin Express
05/07

Modern Chinese Medicine Group Co., Ltd. (MODERN CHI MED) has secured a further waiver from the Hong Kong Stock Exchange regarding Rule 14.41(a) of the Listing Rules, allowing additional time to dispatch its major-transaction circular.

The circular, covering details of the share-purchase agreement, audited financial statements of the target group for the three years ended 31 December 2025, and pro forma financial information of the enlarged group, was originally due on or before 30 April 2026. The revised deadline is now on or before 30 June 2026.

The Stock Exchange granted the waiver on 6 May 2026. The regulator reserves the right to withdraw or amend the waiver should circumstances change.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10